Stock 1110 KINGWORLD MEDICINES GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Kingworld Medicines Group Limited

Equities

1110

KYG5268M1006

Delayed Hong Kong S.E.
Other stock markets
 06:04:31 21/05/2024 BST 		5-day change 1st Jan Change
0.64 HKD 0.00% Intraday chart for Kingworld Medicines Group Limited +10.34% +1.59%
04-23 Kingworld Medicines Posts 68% Jump in 2023 Profit MT
03-26 Kingworld Medicines Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kingworld Medicines Posts 68% Jump in 2023 Profit
Kingworld Medicines Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024
Kingworld Medicines Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Kingworld Medicine Expects Up to 75% Profit Jump in 2023; Shares Up 6%
Kingworld Medicines Group Limited Provides consolidated Earnings Guidance for the Year Ended 31 December 2023
Kingworld Medicines Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Kingworld Medicines Group Expects Up to 40% Rise in H1 Profit
Kingworld Medicines Group Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2023
Kingworld Medicines Group Limited Approves Final Dividend for the Year Ended 31 December 2022
Kingworld Medicines to Invest 832 Million Yen in Taiko Pharmaceutical
Kingworld Medicines to Grant 3.5 Million Awarded Shares Under 2019 Scheme
Kingworld Medicines Group Limited Proposes Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on 30 June 2023
Kingworld Medicines Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022
KIngworld Medicines Group Acquires 60% Stake in Innopharm
Kingworld Medicines Completes Topping Out Process of Longde Health Industrial Park
Kingworld's H1 Profit Jumps
Kingworld Medicines Group Limited Reports Earnings Results for the Half Year Ended June 30, 2022
Kingworld Medicines Group Forecasts Up To 25% Rise in H1 Net Profit
Kingworld Medicines Group Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2022
Kingworld Medicines Group Limited Announces Final Cash Dividend for the Financial Year Ended 31 December 2021, Payable on 30 June 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1110 Stock
  4. News Kingworld Medicines Group Limited
  5. Other languages